.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Deloitte
Chubb
Merck
Teva
Baxter
Daiichi Sankyo
Boehringer Ingelheim
Fish and Richardson
Chinese Patent Office

Generated: June 26, 2017

Lithuania Drug Patents

These international patent data are derived from patent families, based on US drug-patent linkages.
They should not be regarded as comprehensive records of ex-US drug-patent associations.

Document Number Estimated Expiration Equivalent US Patent US Expiry Date Generic Name US Applicant US Tradename
2922530► Subscribe9636407Dec 21, 2032
caspofungin acetate
Fresenius Kabi Usa
CASPOFUNGIN ACETATE
2744810► Subscribe9296769Aug 15, 2032
emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarate
Gilead Sciences Inc
ODEFSEY
2744810► Subscribe9296769Aug 15, 2032
cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate
Gilead Sciences Inc
GENVOYA
2744810► Subscribe9296769Aug 15, 2032
tenofovir alafenamide fumarate
Gilead Sciences Inc
VEMLIDY
2744810► Subscribe8754065Aug 15, 2032
emtricitabine; tenofovir alafenamide fumarate
Gilead Sciences Inc
DESCOVY
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Harvard Business School
Cipla
Fish and Richardson
McKesson
Daiichi Sankyo
Julphar
Federal Trade Commission
Colorcon
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot